Open AccessA quality of life, clinical and biochemical improvements after catheter ablation of persistent arrhythmia in patients with structural heart disease and arrhythmia-mediated cardiomyopathy
Author(s) -
Piotr Gardziejczyk,
Michał M. Farkowski,
Mariusz Pytkowsk,
Karol Kołakowski,
Ilona Kowalik,
Przemysław Leszek,
Krzysztof Jaworski,
Aleksandra Wróbel,
Aleksander Maciąg
Publication year - 2022
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2022.0057
Subject(s) - medicine , interquartile range , heart failure , cardiology , quality of life (healthcare) , catheter ablation , natriuretic peptide , heart disease , atrial fibrillation , nursing
Arrhythmia-mediated cardiomyopathy (AMC) is an essential clinical situation that is commonly underdiagnosed. Successful arrhythmia control leads to improvement in health-related quality of life (HRQoL) and heart failure (HF) symptoms in patients with structural heart disease (SHD).